RCUS11:00 AMNew Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifanarcusbio.com
RCUS8:00 AMArcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancerarcusbio.com
RCUS4:05 PMArcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conferencearcusbio.com
RCUS4:05 PMArcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Updatearcusbio.com
RCUS4:05 PMArcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updatesarcusbio.com